Inotiv, Inc.

    Jurisdiction
    United States
    LEI
    549300FH5Z13X0Q5SK81
    ISIN
    US45783Q1004 (NOTV)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. Read full profile

    Fundamentals

    Net revenue
    €431.00M
    Gross margin
    20.6%
    EBIT
    -€11.23M
    EBIT margin
    -2.6%
    Net income
    -€67.35M
    Net margin
    -15.6%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Neff R Matthew N/A -2K $1.67 -$3.34K
    Neff R Matthew N/A -2K $1.91 -$3.82K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 184K $406.78K -120K Sell

    Earnings Calls

    Latest earnings call: August 7, 2025 (Q3 2025)

    Add to watchlist

    Notifications